| Literature DB >> 18430257 |
Kerstin Malmberg1, Hanna-Linn Wargelius, Paul Lichtenstein, Lars Oreland, Jan-Olov Larsson.
Abstract
BACKGROUND: Pharmacological and genetic studies suggest the importance of the dopaminergic, serotonergic, and noradrenergic systems in the pathogenesis of Attention Deficit Hyperactivity Disorder (ADHD) and Disruptive Behavior Disorder (DBD). We have, in a population-based sample, studied associations between dimensions of the ADHD/DBD phenotype and Monoamine Oxidase B (MAO-B) activity in platelets and polymorphisms in two serotonergic genes: the Monoamine Oxidase A Variable Number of Tandem Repeats (MAO-A VNTR) and the 5-Hydroxytryptamine Transporter gene-Linked Polymorphic Region (5-HTT LPR).Entities:
Mesh:
Substances:
Year: 2008 PMID: 18430257 PMCID: PMC2383890 DOI: 10.1186/1471-244X-8-28
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Figure 1Sample selection procedure.
Attention-deficit and disruptive behavior disorders derived from Kiddie-SADS – PL interviews in a population-based sample of adolescents
| Girls | Boys | Total | ||||
| Diagnosis | n/N* | (%) | n/N* | (%) | n/N* | (%) |
| ADHD inattentive | 4/174 | 2.3 | 4/134 | 3.0 | 8/308 | 2.6 |
| ADHD hyperactive | 2/173 | 1.2 | 7/134 | 5.2 | 9/307 | 2.9 |
| ADHD combined | 0/173 | 0.0 | 1/134 | 0.8 | 1/307 | 0.3 |
| ODD | 1/173 | 0.6 | 2/133 | 1.5 | 3/306 | 1.0 |
| CD | 1/174 | 0.6 | 1/133 | 0.8 | 2/307 | 0.7 |
| CD or ODD | 2/173 | 1.2 | 2/133 | 1.5 | 4/306 | 1.3 |
| Girls | Boys | Total | ||||
| High dimensions of phenotype** | n/N* | (%) | n/N* | (%) | n/N* | (%) |
| ADHD inattentive | 29/174 | 16.7 | 42/134 | 31.3 | 71/308 | 23.1 |
| ADHD hyperactive | 21/173 | 12.1 | 25/134 | 18.7 | 46/307 | 15,0 |
| ADHD combined | 13/173 | 7.5 | 16/134 | 11.9 | 29/307 | 9.5 |
| ODD | 23/173 | 13.3 | 19/133 | 14.3 | 42/306 | 13.7 |
| CD | 9/174 | 5.2 | 15/133 | 11.3 | 24/307 | 7.8 |
| CD or ODD | 25/173 | 14.5 | 25/133 | 18.8 | 50/306 | 16.3 |
*Number of children fulfilling criteria for: diagnosis or high dimensions of phenotype/total number of children
**Dichotomized symptom scale according to possible and certain symptoms (high/low dimensions of phenotype)
Dichotomized symptom scale of ADHD/disruptive behavior and platelet MAO-B activity in girls
| Dichotomized symptom scale | High dimension of phenotype Mean(S.D.) | Low dimension of phenotype Mean(S.D.) | n/N* | p† | p‡ |
| ADHD inattentive | 12.57(2.40) | 13.31(3.53) | 22/140 | 0.381 | 0.631 |
| ADHD hyperactive | 11.99(2.32) | 13.32(3.47) | 15/139 | 0.264 | 0.215 |
| ADHD combined | 11.97(1.95) | 13.25(3.45) | 8/139 | 0.646 | 0.291 |
| ODD | 11.50(2.18) | 13.44(3.46) | 18/140 | ||
| CD | 11.63(1.48) | 13.26(3.42) | 6/140 | 0.227 | 0.167 |
| ODD or CD | 11.52(2.07) | 13.47(3.48) | 20/140 | ||
*Number of children with high dimensions of phenotype/total number of children
† Analyses performed using dichotomized symptom scales
‡ Analyses performed using dimensional scales
Dimensional symptom scales of ADHD and disruptive behavior related to 5-HTT LPR genotype in boys
| Dimensional symptom scale | SS short/short n = 12 Mean(S.D.) | LS long/short n = 47 Mean(S.D.) | LL long/long n = 45 Mean(S.D.) | p† | p‡ |
| ADHD inattentive | 4.17(3.10) | 6.08(4.25) | 4.09(3.73) | 0.867 | 0.122 |
| ADHD hyperactive | 3.17(3.43) | 4.71(4.00) | 3.02(2.97) | 0.990 | 0.089 |
| ADHD combined | 7.33(6.05) | 10.79(7.04) | 7.11(6.43) | 0.928 | 0.064 |
| ODD | 1.00(1.48) | 2.17(2.82) | 1.24(2.05) | 0.817 | 0.079 |
| CD | 1.08(1.68) | 1.49(2.47) | 0.42(1.08) | 0.328 | |
| ODD or CD | 2.08(2.64) | 3.66(4.90) | 1.67(2.86) | 0.651 | |
*Total number with the specific genetic marker
†SS and LL compared
‡LS and LL compared